TLDR
- Cathie Wood ARK ETFs purchased 169,130 Roblox shares worth $13.7 million on January 6, 2026
- ARK Invest sold 19,316 Meta stock shares valued at $12.7 million across ARKK, ARKW, and ARKF
- ARK bought 39,296 Kodiak AI shares worth $409,000 in autonomous driving technology
- ARK trimmed biotech stocks with $1.8 million Guardant Health sale and $568,000 Ionis sale
- Cathie Wood portfolio changes show gaming and AI focus while reducing Meta and healthcare exposure
Cathie Wood’s ARK Invest made major stock trades on January 6, 2026, buying Roblox shares while selling Meta Platforms. The portfolio changes highlight Wood’s strategy shift toward gaming and AI stocks.
ARK ETFs purchased 169,130 Roblox stock shares across three funds. The Roblox buy included ARK Innovation ETF ARKK, ARK Next Generation Internet ETF ARKW, and ARK Fintech Innovation ETF ARKF. Total Roblox stock investment reached $13.7 million.
Cathie Wood’s Roblox investment continues previous buying patterns. ARK has accumulated gaming platform shares over recent sessions. Roblox remains a core holding in Wood’s growth stock portfolio.
ARK sold Meta Platforms stock on the same trading day. The Meta stock sale totaled 19,316 shares across three ETFs. Meta shares sold were valued at $12.7 million.
Cathie Wood Increases AI and Robotics Stock Positions
The Meta Platforms sale extends ARK’s recent selling trend. Wood has reduced Meta stock holdings over multiple trading sessions. The pattern shows declining interest in the social media giant.
ARK purchased Kodiak AI stock through ARKQ robotics ETF. The autonomous driving stock buy totaled 39,296 shares. Kodiak AI investment value reached approximately $409,000.
Cathie Wood has accumulated Kodiak AI shares recently. The autonomous vehicle technology company fits ARK’s innovation focus. AI stocks remain priority investments for Wood’s ETF portfolio.
ARK Invest Sells Healthcare and Biotech Stocks
ARK reduced biotech stock positions on Tuesday. Guardant Health stock sale through ARK Genomic Revolution ETF ARKG totaled 17,613 shares. The Guardant sale was worth $1.8 million.
Ionis Pharmaceuticals stock also saw ARK selling. Wood’s ARKG fund sold 7,228 Ionis shares valued at $568,000. Both healthcare stock sales came from the genomics-focused ETF.
Wall Street analysts maintain different ratings on these stocks. Roblox stock holds Moderate Buy rating with strong upside potential. Meta stock and Kodiak AI stock both have Strong Buy consensus ratings.
Guardant Health and Ionis stocks carry Strong Buy ratings. Healthcare stock upside projections are lower than technology stocks. ARK Invest published trading data in January 6, 2026 daily filing.
